Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
The Lancet Regional Health. Europe|December 13, 2021
Long-term real-world effectiveness of allergy immunotherapy in patients with allergic rhinitis and asthma: Results from the REACT study, a retrospective cohort studyBenedikt Fritzsching, Marco Contoli, Celeste Porsbjerg, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 24, 2005
In contrast to effector T cells, CD4+CD25+FoxP3+ regulatory T cells are highly susceptible to CD95 ligand- but not to TCR-mediated cell deathBenedikt Fritzsching, Nina Oberle, Nadine Eberhardt, et al.
Blood|July 27, 2006
Naive regulatory T cells: a novel subpopulation defined by resistance toward CD95L-mediated cell deathBenedikt Fritzsching, Nina Oberle, Eva Pauly, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 10, 2007
Prevalence of newly generated naive regulatory T cells (Treg) is critical for Treg suppressive function and determines Treg dysfunction in multiple sclerosisJürgen Haas, Benedikt Fritzsching, Petra Trübswetter, et al.
Blood|October 31, 2007
Specific recruitment of regulatory T cells into the CSF in lymphomatous and carcinomatous meningitisJürgen Haas, Laila Schopp, Brigitte Storch-Hagenlocher, et al.
Plos One|January 18, 2022
Stressors faced by healthcare professionals and coping strategies during the early stage of the COVID-19 pandemic in GermanyMarie Ottilie Frenkel, Katja Mareike Pollak, Oliver Schilling, et al.
Pageof 3